Anemoside B4 ameliorates septic cardiomyopathy by activating SRC-mediated PI3K/AKT/mTOR pathway to alleviate mitochondrial dysfunction and cardiomyocyte senescence

International Immunopharmacology 2026

View at publisher
Authors: Yuan Fang, Boshen Yang, Dongfei Zhu, Xue Zhang, Xiyue Jiang, Hanshi Wang, Hanshi Wang, LiLi Zhang, Yin Yu, Yuting Yang, Minjie Yuan, Taixi Li
+4 more Yizhi Chen, Haixiong Wang, Haixiong Wang, Dong Huang
DOI: 10.1016/j.intimp.2025.116108
Cited by: 2
References: 76

Fields of Study & Subjects

Cardiac Ischemia and Reperfusion Cardiac Fibrosis and Remodeling Cardiovascular Function and Risk Factors

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
171
Pages
116108–116108
Publication date
5 January 2026
Language
EN